VANCOUVER, British Columbia & MUMBAI, India–(BUSINESS WIRE)–SaNOtize Research and Development Corp. and Indian company, Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced an exclusive long-term strategic partnership to manufacture, market and distribute SaNOtize’s breakthrough Nitric Oxide Nasal Spray (NONS) for COVID-19 treatment, in India and other Asian markets including Singapore, Malaysia Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam.

Read more here.

The post [SaNOtize in Business Wire] SaNOtize inks agreement with Indian biotech Glenmark to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets appeared first on OurCrowd Blog.

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://blog.ourcrowd.com/glenmark-inks-deal-with-sanotize-for-covid-treatment-spray-in-india-other-asian-markets-2/